Skip to content Skip to content

Press Releases


Filter Releases
 
INCLINE VILLAGE, Nev., March 2, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2009. Total revenues from continuing operations in 2009 were $318.2 million, an eight percent increase from $294.2 million in 2008. For the fourth qu...
INCLINE VILLAGE, Nev., Feb 22, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on Tuesday, March 2 at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and full year 2009, and provide a business update. The call and web...
INCLINE VILLAGE, Nev., Feb 02, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the 12th Annual BIO CEO & Investor Conference in New York City on Monday, February 8, 2010 at 2:00 p.m. Eastern Time. To acc...
INCLINE VILLAGE, Nev., Jan 28, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it will pay two special dividends to its stockholders in 2010. Each of the dividends will be $0.50 per share. The first special dividend will be paid on April 1, 2010 to all stockholders who own shares of PDL on March 15,...
INCLINE VILLAGE, Nev., Jan 21, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (Nasdaq: PDLI) today announced the allocation between dividend income and return of capital for federal income tax purposes for dividends paid in 2009. In 2009, PDL made two cash distributions of $0.50 per share of common stock on April 1, 2009 and October 1, 20...
= add release to Briefcase